Course programme
| |
Facing the world tobacco epidemic P.J. Barnes (London, United Kingdom)
| |
Epidemiology of smoking related respiratory diseases. The role of ENSP P. Behrakis (Athens, Greece)
| |
ERS advocacy in tobacco control policies J.P. Sculier (Brussels, Belgium)
| |
Smokehaz: new ERS website for policy makers C. Gratziou (Athens, Greece)
| |
Addiction to nicotine and relations to other addictions. Psychological dependence D. Fotopoulos (Rethymno, Greece)
| |
Motivation of smokers and patients with smoking related diseases: the case of COPD B. Dautzenberg (Paris, France)
| |
Pharmaceutical treatments (NRTs) P. Tønnesen (Gentofte, Denmark)
| |
Pharmaceutical treatments (Bupropion) I. Mitrouska (Heraklion, Greece)
| |
Pharmaceutical treatments (Varenicline) P. Katsaounou (Athens, Greece)
| |
ERS position paper on smoking cessation in COPD and other pulmonary disorders C. Jiménez Ruiz (Madrid, Spain)
| |
Review of current guidelines for smoking cessation I. Mitrouska (Heraklion, Greece)
| |
Health benefits and motivators of smoking cessation S. Ravara (Lisboa, Portugal)
| |
Smoking and asthma P.J. Barnes (London, United Kingdom)
| |
Smoking and COPD P. Tønnesen (Gentofte, Denmark)
| |
Smoking and oncology patients J.P. Sculier (Brussels, Belgium)
| |
Smoking cessation in psychiatric patients D. Fotopoulos (Rethymno, Greece)
| |
Smoking cessation in CV diseases S. Tonstad (Oslo, Norway)
| |
Smoking and other systems (endocrinology, urology, etc) P. Argyropoulou-Pataka (Thessaloniki, Greece)
| |
Smoking and pregnancy P. Katsaounou (Athens, Greece)
| |
Smoking in adolescents E. Dagli (Istanbul, Turkey)
| |
Smoking cessation in medical education P. Argyropoulou-Pataka (Thessaloniki, Greece)
| |
How to run a smoking cessation clinic C. Jiménez Ruiz (Madrid, Spain)
| |
Smoking cessation clinics in Europe B. Dautzenberg (Paris, France)
| |
Primary prevention of smoking C. Vardavas (Heraklion, Greece)
| |
Passive smoking and children E. Dagli (Istanbul, Turkey)
| |
Passive smoking and CVD. Implementing advice on SHS exposure in clinical practice S. Ravara (Lisboa, Portugal)
| |
New EU tobacco product directive C. Gratziou (Athens, Greece)
| |
Lapses-relapses M. Toumbis (Athens, Greece)
| |
Treatment of relapses S. Tonstad (Oslo, Norway)
| |
Weight gain and smoking cessation P. Katsaounou (Athens, Greece)
| |
Culturally rooted tobacco products: waterpipes, snus, cigars E. Dagli (Istanbul, Turkey)
| |
New smoking cessation products in the pipeline P. Tønnesen (Gentofte, Denmark)
| |
5A - 5R: Motivational interviewing S. Schoretsaniti (Athens, Greece)
| |